CymitQuimica logo

CAS 33510-25-7

:

(8R,9R,10R,11S,12S,13R,14R,15S,18S,19S,20S,21S,22R)-13,14,21,22-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione

Description:
The chemical substance with the name "(8R,9R,10R,11S,12S,13R,14R,15S,18S,19S,20S,21S,22R)-13,14,21,22-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione" and CAS number "33510-25-7" is a complex organic compound characterized by its intricate stereochemistry and multiple functional groups. It features a tetrakis(acetyloxy) moiety, indicating the presence of four acetyl ester groups, which can influence its solubility and reactivity. The compound also contains multiple hydroxyl groups, contributing to its potential as a bioactive molecule. The presence of an epoxy group suggests it may undergo ring-opening reactions, while the dioxacycloheptadecino structure indicates a fused ring system that may impart unique chemical properties. This compound's specific stereochemistry, denoted by the R and S configurations, is crucial for its biological activity and interaction with biological targets. Overall, its complex structure suggests potential applications in pharmaceuticals or as a biochemical probe, although further studies would be necessary to elucidate its specific properties and functions.
Formula:C36H45NO17
InChI:InChI=1S/C36H45NO17/c1-15-16(2)31(44)53-28-26(50-19(5)40)30(52-21(7)42)35(14-47-17(3)38)29(51-20(6)41)25(49-18(4)39)23-27(43)36(35,34(28,9)46)54-33(23,8)13-48-32(45)22-11-10-12-37-24(15)22/h10-12,15-16,23,25-30,43,46H,13-14H2,1-9H3/t15-,16-,23+,25+,26-,27?,28-,29+,30-,33-,34-,35+,36-/m0/s1
InChI key:InChIKey=NKTOESKXBIEREY-UFVATRKSSA-N
SMILES:C(OC(C)=O)[C@@]12[C@@]34C(O)[C@@]([C@@H](OC(C)=O)[C@H]1OC(C)=O)([C@@](C)(O3)COC(=O)C=5C([C@@H](C)[C@H](C)C(=O)O[C@]([C@]4(C)O)([C@H](OC(C)=O)[C@@H]2OC(C)=O)[H])=NC=CC5)[H]
Synonyms:
  • (8R,9R,10R,11S,12S,13R,14R,15S,18S,19S,20S,21S,22R)-13,14,21,22-Tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-8,11-epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione
  • Neoeuonymine
  • Evonine, 8-(acetyloxy)-O6-deacetyl-8-deoxo-, (8α)-
  • 8,11-Epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione, 13,14,21,22-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-, [8R-(8R*,9R*,10R*,11S*,12S*,13R*,14R*,15S*,18S*,19S*,20S*,21S*,22R*)]-
  • 8,11-Epoxy-9,12-ethano-11,15-methano-11H-[1,8]dioxacycloheptadecino[4,3-b]pyridine-5,17-dione, 13,14,21,22-tetrakis(acetyloxy)-12-[(acetyloxy)methyl]-7,8,9,10,12,13,14,15,18,19-decahydro-10,20-dihydroxy-8,18,19,20-tetramethyl-, (8R,9R,10R,11S,12S,13R,14R,15S,18S,19S,20S,21S,22R)-
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 1 products.